Injectable medicine for endometriosis pain
Part of Women’s health & pregnancy clinical trials.
This study tests an investigational injectable medicine for endometriosis and compares it with an approved drug. It aims to see if the new medicine works as well and is safe. Women with endometriosis who are not planning to get pregnant may join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 45 and weigh at least 40 kg
- You have been diagnosed with endometriosis (by biopsy, ultrasound, or MRI)
- You have regular menstrual cycles between 21 and 35 days before screening
- You agree not to try to get pregnant and use effective birth control (like condoms or an IUD) for 3 months after treatment
- You have not used hormone medicines (like birth control pills) or other endometriosis treatments recently
- You are free from serious health conditions like osteoporosis, epilepsy, depression, or blood clots
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called HHK001 for endometriosis. It is compared with a standard treatment (Enantone) to see if it is safe and works well to reduce symptoms.
This trial tests a drug called GnRH agonist to see if it helps people with endometriosis cysts. It might offer a new treatment option for those with this condition.
This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.
This trial is testing a medicine called Relugolix to see if it helps reduce pain related to endometriosis. If you have confirmed endometriosis and are already taking Relugolix for at least a month with significant pain, this study might be for you.
Hear when a new Endometriosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.